Axillary lymph node surgery choices for HER2+ and triple-negative breast cancer
Part of Cancer, Skin clinical trials.
This study examines the best surgical approach for removing underarm lymph nodes in patients with HER2-positive or triple-negative breast cancer who have received chemotherapy before surgery and still have cancer in their lymph nodes. The goal is to understand whether removing more lymph nodes improves outcomes for these patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with stage I–III HER2-positive or triple-negative breast cancer (not spread to other organs at diagnosis)
- Received chemotherapy before surgery to shrink the tumor
- Had sentinel lymph node surgery or similar imaging-guided lymph node removal procedure
- Cancer cells larger than 2 mm found in lymph nodes after chemotherapy and surgery
- Surgery completed by October 2024 with at least 1 year of follow-up information available
- Not a hormone-receptor-positive breast cancer (unless hormone receptors are very low)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the safest and most useful way to remove and check breast-cancer lymph nodes in the armpit after you finish chemotherapy given before surgery. It may help you avoid unnecessary surgery while still getting accurate information about how well the treatment worked.
This study looks at a less invasive way to remove underarm lymph nodes in breast cancer patients who have one or two abnormal nodes seen on ultrasound. It checks if removing just the sentinel node and a wire-marked node is enough, avoiding removal of all underarm nodes when possible.
This study tests whether patients with advanced breast cancer (with lymph node involvement) who shrink their cancer with chemotherapy before surgery can safely skip complete lymph node removal and just have a smaller sentinel node procedure instead. The goal is to reduce surgery-related side effects while maintaining good cancer outcomes.
This trial compares two treatments for people with breast cancer that has spread to the lymph nodes: radiation therapy to the armpit or surgery to remove the lymph nodes. The goal is to see which approach works best after a tailored surgery to remove the most suspicious lymph nodes.
This trial compares two ways to treat the underarm lymph nodes in people whose sentinel lymph node still shows limited cancer after chemotherapy and hormone treatment. It may help find which approach controls cancer better with fewer side effects.
This study looks at whether some breast cancer patients can safely skip a surgery that removes lymph nodes in the armpit after their initial (pre-surgery) treatment shows the armpit is likely clear. It may reduce surgical side effects if the armpit truly responds well.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.